3Grandi Am, Venco A, Barzizza F, et al. Double-blind comparison of perindopril and captopril in hypertension: effects on left ventricular morphology and function. Am J Hypertens,1991,4:516-526.
4Asmar RG, Journo HJ, Lacolley PJ, et al. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension. J Hypertens,1988,6(Suppl 3):s33-39.
5Cheorghiade M, Cody RJ, Francis GS,et al. Current medical therapy for advanced heart failure. Am Heart J,1998,132(Suppl):s231-248.
6Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.The SOLVD Investigators. N Engl J Med, 1991,325:293-302.
7Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).The CONSENSUS Trial Study Group. N Engl J Med,1987,316:1429-1435.
8Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on Evaluation and Management of Heart Failure). Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol,1995,26:1376-1398.
9Sharpe N, Murphy J, Smith H, et al. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet, 1988,1:255-259.
10Sharpe N, Smith H, Murphy J, et al. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting- enzyme inhibition. Lancet, 1991,337:872-876.
3Kim S,Ohta K,Hamaguchi A,et al.Angiotensin Ⅱ induces cardiac phenotypic modulation and remodeling in vivo in rats[J].Hypertension,1995,25(6):1 252-1 259.
4Nahrendorf M,Frantz S,Hu K,et al.Effect of testosterone on post-myocardial infarction remodeling and function[J].Cardiovasc Res,2003,57(2):370-378.
5Nagaya N,Goto Y,Nishikimi T,et al.Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction[J].Clin Sci,1999,96(2):129-136.
